BML-277 (Chk2 Inhibitor II), 10mM/1mL

BML-277 (Chk2 Inhibitor II), 10mM/1mL

Selitrectinib (LOXO-195), 25mg

Selitrectinib (LOXO-195), 25mg

Selitrectinib (LOXO-195), 5mg

1.245,93 RON
SKU
SKM_S8636_5mg

Selitrectinib (LOXO-195, BAY 2731954) is an orally available, highly potent, and selective TRK kinaseinhibitor with low nanomolar inhibitory activity against TRKA G595R, TRKC G623R, and TRKA G667C, IC50s ranging from 2.0 to 9.8 nmol/L. It is more than 1,000-fold selective for 98% of non-TRK kinases tested.

Mai multe informatii
Price 1.047,00 RON (preturile sunt fara TVA)
Description

Selitrectinib (LOXO-195, BAY 2731954) is an orally available, highly potent, and selective TRK kinaseinhibitor with low nanomolar inhibitory activity against TRKA G595R, TRKC G623R, and TRKA G667C, IC50s ranging from 2.0 to 9.8 nmol/L. It is more than 1,000-fold selective for 98% of non-TRK kinases tested.